Evidence map›Paper›PMID 39585633›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Quantification of Neutralizing Antibodies in Serum Using VSV-MARV-GFP.

Paige Fletcher

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Paige FletcherLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA. paige.fletcher@nih.gov.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutralizing antibodies play an important role in protection against filoviruses. However, the technique to assess neutralization titers with a replicating BSL-4 virus is limited. This chapter explains how to determine the neutralization titer in serum samples against Marburg virus (MARV). This method uses a replicating recombinant vesicular stomatitis virus expressing the MARV glycoprotein and the green fluorescent protein as a surrogate approach.

Indexed as

Antibodies, NeutralizingAntibodies, ViralGreen Fluorescent ProteinsMarburgvirusNeutralization TestsAnimalsHumansVesicular stomatitis Indiana virusVesiculovirusAntibodies, NeutralizingAntibodies, ViralGreen Fluorescent ProteinsFilovirusGlycoproteinMarburg virusNeutralizationVesicular stomatitis virus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.